Demand Diversity - COVID-19 Research
Demand Diversity - COVID-19 Research
Demand Diversity - COVID-19 Research
IMPACT OF COVID-19
ON HIGH-RISK
INDIVIDUALS IN THE UK
demanddiversity.co
INTRODUCTION
– Black, Asian and minority ethnic communities are underrepresented in clinical trials.1
– The risk of death from COVID-19 is generally higher among Black, Asian and minority ethnic
communities than white people. Due to this, there is a demand for more diverse participants
to take part in clinical trials to ensure the effectiveness and safety of the vaccine.2
– The race to find a vaccine to combat the COVID-19 pandemic has forced clinical trial sponsors
to re-assess their patient recruitment strategies to be more inclusive.3
– Demand Diversity has conducted extensive research within the UK, using participants of a
variety of ages, occupations and ethnicities, to understand their perceptive on the pandemic,
clinical trials and general healthcare.
– The research took a mixed quantitative and qualitative approach, with an online survey
and in-depth interviews conducted.
– This report highlights key insights from the research, including patients’ concerns, how
COVID-19 continues to impact them, their thoughts on clinical trials, and their opinions on
how to make healthcare more inclusive.
1. https://www.tandfonline.com/doi/abs/10.1080/13557858.2016.1182126
2. https://coronavirusexplained.ukri.org/en/article/cad0011/
3. https://blogs.deloitte.co.uk/health/2020/10/diversity-and-inclusion-in-clinical-trials-an-imperative-especially-in-times-of-covid-19.html
CONTENTS
05 EXECUTIVE SUMMARY
08 METHODOLOGY
10 DEMOGRAPHICS
39 CONCLUSION
EXECUTIVE
SUMMARY
EXECUTIVE SUMMARY OF SURVEY – People are generally very worried and apprehensive about the COVID-19 pandemic.
The results show that individuals from ethnic minority groups are generally more scared
of the pandemic compared to white people.
– 66% of participants stated that they had a specific illness. However, only 33% of all
participants were informed by healthcare professionals that they class as high risk.
– 23.6% of key workers stated that they had, or have, COVID-19 compared to
10.8% of the rest of the participants.
– Although the majority of people had never taken part in a clinical trial, over 60% of
people who did were white. Less than a quarter of people were Asian or Asian British.
– People are generally aware that COVID-19 clinical trials are taking place, but most
people would not consider taking part. A huge 94% of the Black ethnic group stated
they would not take part compared with 75% of white people.
– Those from the Black ethnic group are particularly sceptical of clinical trials, due to
a lack of trust in the system.
– Being provided with clear information, and informed of the potential risks or side effects,
are seen to be the most important factors when considering to take part in a trial.
Surveys carried out August and September 2020 and respondents were entered into a prize draw to win a gift card at random for their participation
EXECUTIVE SUMMARY OF INTERVIEWS
– COVID-19 has impacted ethnic minority communities in similar ways.
However, different concerns and priorities were raised by the Indian community.
– Ethnic minority groups, particularly from the Black community, were offended by
the statement that ‘ethnic minority people are more likely to die from COVID-19’
as it implied weakness.
– Across all groups, healthcare is an extremely taboo topic of conversation.
It is believed this is a key reason for the lack of participation in clinical trials.
– People are aware that ethnic minority groups are underrepresented in healthcare
and clinical trials.
– Reaching out to community centres and societies, and advertising clinical research onto
Asian TV channels, were suggested as ways to further encourage communities to take part.
– There are doubts that trust can ever be fully regained in ethnic minorities and healthcare.
– There is some awareness for cultural competency and the lack there of it.
Interviews carried out September 2020 and respondents received a gift card for their participation
METHODOLOGY
METHODOLOGY
PARTICIPANT RECRUITMENT
The Facebook ad copy and imagery The Facebook ads then appeared on the
were composed with ethnic social platforms of people living near these
minority participants in mind, to locations, thus giving us a more diverse
further increase this reach. range of participants.
DEMOGRAPHICS
SURVEY DEMOGRAPHICS
ETHNICITY GENDER AGE
37.5% 36.5% Female
18
Male
1.9%
73.1% 18–29
30
2.9%
0% 16% 46% 80+
N = 409
SURVEY DEMOGRAPHICS Illnesses / condition
83 30 31
Asthma Heart Disease COPD
97 140 9
Diabetes Hypertension Arthritis
8 3 9
Chronic Kidney Disease Parkinson’s Disease Liver Disease
3 30
Multiple Sclerosis Other
N = 271
Yes
I know someone
who has
22.7% 23.6%
of key workers
stated that they
No 66.5% have, or have had,
COVID-19. This
is much more than
the average across
10.8% all participants.
Yes
I have
N = 406
DATA ANALYSIS
ON A SCALE OF 1–7, HOW CONCERNED ARE YOU ABOUT COVID-19?
(1 = not at all, 7 = extremely concerned)
All responses
7.5%
4.7%
7.0%
11.2%
21.4%
13.9%
34.6%
Not at all Extremely concerned
N = 402
DATA ANALYSIS
ON A SCALE OF 1–7, HOW CONCERNED ARE YOU ABOUT COVID-19?
(1 = not at all, 7 = extremely concerned)
Ethnic minority
groups are
With 66%
of participants
having stated they
had an illness; it
No 66.8% 33.2% Yes is surprising that
only 33%
were told they
class as high risk
N = 397
DATA ANALYSIS
HAVE YOU TAKEN PART IN A CLINICAL TRIAL?
61%
of people who
had taken part in
Yes a clinical trial before
2.7% I know someone are from the white
No 92.3% who has
ethnic group.
5.0% Yes
I have
22%
were from the
Asian / Asian British
ethnic group.
N = 363
DATA ANALYSIS
ARE YOU AWARE THAT CLINICAL TRIALS ARE
TAKING PLACE TO TEST COVID-19 VACCINES?
85.6% 14.4%
Yes No
26.2% 73.8%
Yes No
N = 367
DATA ANALYSIS
DIFFERENCES BETWEEN ETHNIC GROUPS
(Likelihood of taking part in a COVID-19 vaccine trial)
5.7% 94.3%
Yes No
There is a
significant
Asian / Asian British ethnic groups
difference
between the Black /
29.5% 70.5% African / Caribbean /
Yes No
Black British ethnic
group compared to
the others
White ethnic groups
25% 75%
Yes No
DATA ANALYSIS
HOW DOES THIS DIFFER (IF AT ALL) TO HOW LIKELY YOU ARE
TO TAKE PART IN A CLINICAL TRIAL FOR ANOTHER ILLNESS?
(Thinking about how likely you are to take part in a COVID-19 vaccine clinical trial)
60%
50.2%
People are
40% more
28.5%
reluctant
to take part in
21.3% COVID-19 clinical
20% trials compared to
other illnesses
0%
More likely Equally likely Less likely
N = 263
DATA ANALYSIS
HOW DOES THIS DIFFER (IF AT ALL) TO HOW LIKELY YOU ARE
TO TAKE PART IN A CLINICAL TRIAL FOR ANOTHER ILLNESS?
Those who are more likely to take part in a COVID-19 vaccine clinical trial…
61.7% feel it is crucial to take part 27.7% would take part in the
as it is important or urgent that we find a clinical trial as they would like to help find a
cure / vaccine for coronavirus: cure for the greater good:
N = 56
DATA ANALYSIS
HOW DOES THIS DIFFER (IF AT ALL) TO HOW LIKELY YOU ARE
TO TAKE PART IN A CLINICAL TRIAL FOR ANOTHER ILLNESS?
Those who are less likely to take part in a COVID-19 vaccine clinical trial…
“Because the side effect might be “I have concerns about earlier statements
as bad as the corona itself” made by government ministers using
“It is a new virus so no one knows what black people to trial untested drugs”
they’re doing, it's all an experiment”
N = 134
DATA ANALYSIS
WHAT DO YOU THINK WOULD MAKE YOUR FAMILY / FRIENDS
WANT TO OR NOT WANT TO TAKE PART IN A COVID-19 VACCINE
CLINICAL TRIAL?
(Thinking about your family / friends who are at risk of being seriously ill from COVID-19. For example,
those in Black, Asian and minority ethnic groups, the elderly or individuals with certain conditions such as
asthma or heart disease.)
The majority of people discuss the risk of negative side effects, their safety, and the fear of the unknown with clinical
trials. Some people mention that these individuals may feel like guinea pigs in trials.
“If the clinical trial is not safe and would give you “What the government is saying, that it affects
side effects. Also not getting any information about it black people more, makes us believe they want
and no company information on how safe it is” to use us as guinea pigs”
“They need to be open and honest about possible “The risks they are taking. In the event of failure
effects. There is a fear of harm from trials and a lack (worst case scenario), they will be leaving behind loved
of trust in the system carrying out the research” ones who will feel they lost someone unnecessarily”
N = 180
DATA ANALYSIS
IF YOU WERE DECIDING TO TAKE PART IN A CLINICAL TRIAL
FOR A COVID-19 VACCINE, HOW IMPORTANT WOULD THE
FOLLOWING FACTORS BE TO YOU?
Having access to a website with information about the clinical trial People believe
Knowing I’d be given updates about how the clinical trial is going receiving clear
Having a leaflet to take home with information about the clinical trial
information and the
potential side effects
How safe I feel going to a hospital
are the most
The potential benefits to me and others
important factors,
How far I have to travel to the appointments
demonstrating that
people like
How it affected my ability to carry on working
0 40 80 120 160
DATA ANALYSIS
HOW DIFFERENT WOULD YOU FEEL ABOUT JOINING A
CLINICAL TRIAL IF YOU KNEW THE PERSON ASKING YOU TO
TAKE PART HAD A GOOD UNDERSTANDING OF AND RESPECT
FOR YOUR CULTURE AND/OR RELIGION?
60%
Interestingly, people
don’t believe that
40%
cultural understanding
would impact their
decision to take part;
could this be
20%
an unconscious
factor?
0%
Less likely More likely No different N/A
N =239
THEMATIC
ANALYSIS
INTERVIEW DEMOGRAPHICS 7 x 30-minute interviews
were conducted to gain a more in-depth understanding into the opinions of people from ethnic
minority communities. The aim was to understand how the wider community also felt regarding
coronavirus and clinical trials.
Ethnicity
Pakistani Hispanic
Disease areas
Although all people expressed emotional concern with COVID-19, such as not
being able to see family and friends, there appeared to be distinct differences
between communities.
The Indian community expressed concerns over the rituals and ceremonies that
usually follow when someone dies:
It’s more than just
worrying about
As the Indian community have rituals and ceremonies when someone dies, their biggest
negative symptoms;
concern is not being able to say goodbye to their loved ones if one was to pass away from
coronavirus in the correct way.” - INDIAN social distancing is
taking over culture
and tradition in
One participant highlighted this concern across her wider community as well: an emotionally
detrimental way
We have ceremonial things – we dress them up and “My friends mother died and she’s
do their makeup – and with coronavirus we can’t do very angry that she did all these
that. I have a friend whose husband died and without regulations that the government
anyone knowing, she did her prayers with him whilst have set out, as she couldn’t do
at home, so that she was able to.” - INDIAN anything for the mother.” - INDIAN
THEMATIC ANALYSIS
ETHNIC MINORITY GROUPS MORE AT RISK OF COVID-19
Individuals from Black, Asian and minority ethnic groups express awareness that they
are more at risk of COVID-19 but feel frustrated by how the government has handled
the situation.
People believe that by highlighting this difference in risk, they are unnecessarily singled
out and worries are heightened.
This could stem from
“You read that black people are more susceptible to catching coronavirus,
which isn’t helpful at all as it makes you even more worried.” – BLACK AFRICAN a lack of
cultural safety;
People are offended as they feel the media has portrayed ethnic minority groups as not dealing with
‘genetically weaker’. It is believed that this communication style has discouraged situations and
ethnic minorities groups to take part in clinical trials in the past, and this has become information in the most
well rooted in society. They feel anxious that they are ‘guinea pigs’ in the clinical trials. appropriate way
“The thing that became annoying is that “If we look at other countries where these
people were saying Black and Asian ethnic people had families, at that time people were
minority people are more predisposed to not dying in Africa or the Caribbean, it was just
catching coronavirus, so already they were people who lived in big cities. So I think it was
calling us weaker genetically.” quite offensive actually and it took people
- INDO CARIBBEAN back a bit.” – INDO CARIBBEAN
THEMATIC ANALYSIS
HEALTHCARE IS A TABOO TOPIC
This could explain why these communities take part in clinical trials less frequently.
It appears that these communities take ‘less risks’, and therefore would not be
prepared to take any chances with their health in a clinical trial.
In order to break
“I think healthcare needs cultural competency. In the South Asian community, older women do not the stigma,
know how to explain mental health problems. They complain about back pain, stomach pain, but they community leaders
are describing anxiety or depression. But unless you know the questions to ask people, this doesn’t within these
come out. For some cultures, psychological symptoms are alien words.” – SOUTH ASIAN
communities must
speak up to
“Death is a taboo word – no one talks about it. No one wants to admit that they have an illness normalise these
because it is linked to death and people do not want to become untouchable. People like to gossip
about this. My experience in the NHS, if anyone was close to death, it is not an acceptable thing conversations
because they always believe that God will make it alright." – INDIAN
“In African communities, if people pass away from cancer, they don’t mention it, it’s very secretive.
I think it’s just a taboo in our society and people don’t like to be associated with those types of things.
In the white community they are very honest but, in our community, they don’t like to share
those personal details.” – BLACK AFRICAN
THEMATIC ANALYSIS
AWARENESS OF UNDERREPRESENTATION IN HEALTHCARE
People are mostly aware that ethnic minority groups are underrepresented in
clinical trials.
For the most part, people believe this is due to the groups being ‘tight-knit’ and
‘hard to reach’, as well as the lack of trust they have in the healthcare industry.
It is apparent that people don’t want to be the first to try something risky:
“People in our community don’t donate blood as much as the white community either.
It’s hasn’t existed in our community for many years so its difficult.” - BLACK AFRICAN
THEMATIC ANALYSIS
ENCOURAGING ETHNIC MINORITY GROUPS TO TAKE PART…
Many of the people we interviewed believe visiting community centres and places of
worship is the most successful way to try and change negative perceptions of clinical
trials. Advertising on Asian TV channels was also deemed as the best way to connect
with this community as people will trust information showed on there:
Although there is a big preference for going out and talking to the community,
people are still skeptical about how well this will work given the level of mistrust
that already exists.
“Even as a diabetes nurse, it took a “The government will find it very Ultimately,
long time to get people to believe that
diabetes is going to harm you, it slowly
difficult to gain their trust as they feel
undervalued for so long – and they there is no
trickled into the communities and
they’re becoming more aware
have been. I’m not sure how you can
get their trust back – aside from
easy route
of it. It’s more than just one going out there and talking to the when it comes to
campaign, it’s a long process.” community. But that takes a while.” improving diversity
– INDIAN – HISPANIC in healthcare
Behaviours are so deeply rooted into their culture, it’s going to take a lot of work
to change. It’s about building relationships within a community and encouraging
the ‘information to trickle in’. It’s not something that can be combatted with a
‘one-off campaign’.
THEMATIC ANALYSIS
PERSONAL EXPERIENCE
One participant explained their experiences with community outreach and the
difficulties they faced when communicating with ethnic minority groups.
“I’ve worked with a lot of communities when I worked in the The difficulty is often
council, where there’s a massive minority ethnic population. with the design of the
recruitment materials.
We sent thousands of people information when we worked
on advertising free school meals. They don’t read it. We put up leaflets How can we
in community centres, schools, blitzed every house with them and
they still didn’t come forwards to redeem the free meals.
make this more
readable and
They only came forwards when their Mullah at the mosque
told them. Their children wouldn’t get fed otherwise. trustworthy?
They didn’t read anything unless they thought it was official..
About 70% didn’t come forwards for the free meals.”
- HISPANIC
THEMATIC ANALYSIS
THE IMPACT OF CULTURAL SAFETY
PAPER OR DIGITAL?
“Majority of our people are not very good with
Overall there was a preference for digital leaflets to be sent via email,
computers and struggle to read emails.
as this is a more cost- and environmentally-effective way. However, there Even very well-off people” - INDIAN
were comments about the older generation struggling with technology.
IS LANGUAGE IMPORTANT?
Overall, people believe using different languages is important to “I think language is really important.
You have to know who you’re sending the
encourage people to take part. People will take more notice of it if it’s information to first of all” - INDO CARIBBEAN
written in their language.
CONCLUSION
CONCLUSION What we have found Future implications
Ethnic minority groups are more reluctant Clinical trial sponsors, as well as the health
to take part in clinical trials. They are aware industry at large, must develop more trusting
they are underrepresented in clinical trials, relationships with ethnic minority groups. This
namely due to social norms, mistrust in the can be done by integrating within the communities
health system, and a lack of effort made and with personalised advertisements.
from healthcare professionals.
One way to improve communications and
Healthcare generally is a taboo topic across relationships between clinical trial sponsors and
the different ethnic minority groups. people from minority ethnic groups is through
education. Cultural safety training is an important
Approaching community centres and
way to equip sites with the knowledge and tools to
advertising on local TV stations is the most
be more inclusive when working with a diverse
effective way to advertise for a clinical trial.
group of study participants.
Improving diversity in healthcare is not an
More research is needed to explore the most
easy win. A lot of long-term work is needed
optimal ways to filter health information into
to build trusting relationships.
close-knit ethnic minority communities, to build
trust and to improve diversity in healthcare.
COUCH HEALTH WOULD LIKE TO THANK ALL THE PARTICIPANTS WHO CONTRIBUTED TO THIS RESEARCH.
demanddiversity.co
couchhealth.co
This report (including any attachments) has been prepared for the exclusive use and benefit of the addressee(s) and solely for the purpose
for which it is provided. All report information is correct as of December 2020. Unless COUCH Health provide prior written consent, no part
of this report should be reproduced, distributed or communicated to any third party. COUCH Health do not accept any liability if this report
is used for an alternative purpose from which it is intended, nor to any third party in respect of this report.